Refine by
Preclinical Drug Articles & Analysis
57 news found
By leveraging a suite of biomimetic and AI-powered technologies, BBBporter™ enables the efficient transport of therapeutic candidates into the brain, opening new avenues for preclinical drug development in areas such as Alzheimer's disease, Parkinson's disease, stroke, and epilepsy. ...
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the expansion and enhancement of its comprehensive Drug Discovery Services to help scientists advance antiviral therapeutic development, including target selection and validation, hit selection and optimization, and preclinical development. ...
Yang, L., et al (2024) introduces LungVis 1.0, an AI-driven imaging platform integrating light sheet fluorescence microscopy (LSFM) and deep learning for mapping nanoparticle (NP) deposition across murine lungs. The research highlights the advantages of aerosol-based delivery methods over traditional liquid-based approaches, emphasizing the uniformity of NP deposition in distal alveolar ...
As of the latest research, several experimental gene therapies for glaucoma are in various stages of development, from preclinical studies to early-phase clinical trials. As an innovative ophthalmic disease research company with a wide range of services in basic research, drug development, and preclinical studies, Ace Therapeutics has expanded ...
Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive scarring of the lungs, which severely impairs lung function over time. Developing effective treatments for IPF has been a challenge for the medical community, as the mechanisms driving this disease are complex and not fully understood. To accelerate drug discovery, animal models that closely mimic the ...
Ace Therapeutics, a preclinical contract research organization (CRO) actively engaged in mental illness research, has announced the launch of its model development services, which aim to revolutionize psychiatric drug research and development. ...
Ace Therapeutics is a preclinical contract research provider engaged in ophthalmic diseases. To help pharmaceutical partners and academic institutions overcome the challenges of low bioavailability and unsustainable drug release in drug formations for glaucoma, Ace Therapeutics is proud to announce the unveiling of its cutting-edge ...
Having earned a strong reputation for its expertise in GLP services, Protheragen-ING Lab offers a wide range of preclinical and clinical services to support drug development. The launch of Protheragen-ING Lab's medical device services marks a significant milestone in the company's evolution, further solidifying its position as a leader in the life sciences ...
“As the demand for innovative drugs continues to grow, the need for rigorous preclinical research has become paramount. ...
Gayathri Swaminath, PhD, MBA, Senior Vice President of Discovery, brings over 17 years of preclinical and translational research and drug development experience. ...
The estimated cost of a failed trial ranges from $800 million to $1.4 billion. 6.Problem setting priorities Clinical trial development involves discovery and development, preclinical research, drug development, FDA review, etc. When working through each phase, a leader decides which tasks should be taken care of first based on the priority. ...
VeriSIM Life has developed a whole-body biosimulation platform driven by AI and machine learning (ML), that accurately predicts the clinical efficacy of new drugs before human trials. We are delivering strategic insights from our platform to translate, scale, and accelerate drug development to advance human health. ...
VeriSIM Life provides insights to pharma, biotech, academia, and research institutions and conducts risk-sharing collaborations to develop promising drugs, paving the preclinical development roadmap with AI. The company integrates comprehensive existing databases and animal models into its bio-simulation system, accelerating preclinical ...
In the process of drug development, the evaluation of drug effectiveness is one of the keys to determining whether prodrugs can sufficiently reach the market stage. ...
In the paper, ‘Predicting Regioselectivity of AO, CYP, FMO and UGT Metabolism Using Quantum Mechanical Simulations and Machine Learning’, the team combined existing experimental results, quantum mechanics and machine learning to build predictive models for drug metabolism. [1] The research will underpin the development of new capabilities for StarDrop™, enabling ...
Collectively, the data strengthens the rationale to progress the development of the drug candidate in other chronic inflammatory diseases where mPGES-1 plays a key role. Last year, Gesynta Pharma initiated an extensive evaluation of the drug candidate in a preclinical disease model of endometriosis - a painful inflammatory disease affecting ...
Canaquest Medical Corp (OTC Pink:CANQF) (the "Company" or "CanaQuest"), an award-winning, Clinical Stage/Life-Sciences company focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors, today announced its US launch of all-natural Mentanine® (cannabidiol "CBD" + IP, Omega-3s, DHA, EPA formula) in ...
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning, Clinical Stage/Life-Sciences company focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors, today announced its US launch of all-natural Mentanine (cannabidiol “CBD” + IP, Omega-3s, ...
Our scientists will help fellows proceed with mitochondria-focused design, validation, and test experiment in support of preclinical stages of pharmaceutical drug development," the marketing manager at Creative Biogene said. ...
” As a leading CRO in the preclinical stage, BOC Sciences leverages its drug delivery systems and capabilities of siRNA synthesis & modification to identify novel ligands against the selected target receptors, thus facilitating the delivery of drug payloads for a broad range of tissues and cells. About BOC Sciences In possession of ...